These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8708595)

  • 1. Should metformin be used to improve blood lipid pattern in nondiabetic patients with coronary heart disease?
    Hoogeveen EK; Stehouwer CD
    J Intern Med; 1996 Jul; 240(1):46-7. PubMed ID: 8708595
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
    Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
    Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine and cardiovascular risk in patients with diabetes mellitus.
    Yeromenko Y; Lavie L; Levy Y
    Nutr Metab Cardiovasc Dis; 2001 Apr; 11(2):108-16. PubMed ID: 11434188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study.
    Kilicdag EB; Bagis T; Zeyneloglu HB; Tarim E; Aslan E; Haydardedeoglu B; Erkanli S
    Hum Reprod; 2005 Apr; 20(4):894-9. PubMed ID: 15618250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipids in polycystic ovary syndrome: role of hyperinsulinemia and effects of metformin.
    Banaszewska B; Duleba AJ; Spaczynski RZ; Pawelczyk L
    Am J Obstet Gynecol; 2006 May; 194(5):1266-72. PubMed ID: 16647909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin: a safe and effective treatment in the management of NIDDM.
    Kilo C
    Mo Med; 1997 Mar; 94(3):114-23. PubMed ID: 9071866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine and steroids levels in metformin treated women with polycystic ovary syndrome.
    Vrbíková J; Bicíková M; Tallová J; Hill M; Stárka L
    Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):74-6. PubMed ID: 11928069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin use in decompensated heart failure.
    Boyd A; Nawarskas J
    Cardiol Rev; 2008; 16(5):269-72. PubMed ID: 18708828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of melatonin and zinc on lipid profile and renal function in type 2 diabetic patients poorly controlled with metformin.
    Kadhim HM; Ismail SH; Hussein KI; Bakir IH; Sahib AS; Khalaf BH; Hussain SA
    J Pineal Res; 2006 Sep; 41(2):189-93. PubMed ID: 16879326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis.
    Pantalone KM; Kattan MW; Yu C; Wells BJ; Arrigain S; Jain A; Atreja A; Zimmerman RS
    Acta Diabetol; 2009 Jun; 46(2):145-54. PubMed ID: 19194648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of metformin and rosiglitazone on postprandial lipid metabolism in obese insulin-resistant subjects.
    James AP; Watts GF; Mamo JC
    Diabetes Obes Metab; 2005 Jul; 7(4):381-9. PubMed ID: 15955124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30.
    Glueck CJ; Fontaine RN; Wang P; Subbiah MT; Weber K; Illig E; Streicher P; Sieve-Smith L; Tracy TM; Lang JE; McCullough P
    Metabolism; 2001 Jul; 50(7):856-61. PubMed ID: 11436194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin improves skin capillary reactivity in normoglycaemic subjects with the metabolic syndrome.
    Kraemer de Aguiar LG; Laflor CM; Bahia L; Villela NR; Wiernsperger N; Bottino DA; Bouskela E
    Diabet Med; 2007 Mar; 24(3):272-9. PubMed ID: 17263761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS; Aslam M; Naveed AK; Razi MS
    Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin therapy improves coronary microvascular function in patients with polycystic ovary syndrome and insulin resistance.
    Topcu S; Tok D; Caliskan M; Ozcimen EE; Gullu H; Uckuyu A; Erdogan D; Zeyneloglu H; Muderrisoglu H
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):75-80. PubMed ID: 16817823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.
    Strowig SM; Raskin P
    Diabetes Obes Metab; 2005 Nov; 7(6):633-41. PubMed ID: 16219007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender-related differences in the relationship between plasma homocysteine, anthropometric and conventional biochemical coronary heart disease risk factors in middle-aged Indians.
    Pitla S; Nagalla B
    Ann Nutr Metab; 2009; 54(1):1-6. PubMed ID: 19194102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: a randomized, double-blind, placebo-controlled study.
    Jadhav S; Ferrell W; Greer IA; Petrie JR; Cobbe SM; Sattar N
    J Am Coll Cardiol; 2006 Sep; 48(5):956-63. PubMed ID: 16949486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin--the gold standard in type 2 diabetes: what does the evidence tell us?
    Bosi E
    Diabetes Obes Metab; 2009 May; 11 Suppl 2():3-8. PubMed ID: 19385978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of metformin on the incidence of type 2 diabetes mellitus and cardiovascular disease risk factors in overweight and obese subjects--the Carmos study.
    Andreadis EA; Katsanou PM; Georgiopoulos DX; Tsourous GI; Yfanti GK; Gouveri ET; Diamantopoulos EJ
    Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):175-80. PubMed ID: 19053032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.